Directly observed therapy and improved tuberculosis treatment outcomes in Thailand

PLoS ONE

Volumn 3, Issue 8, 2008, Pages

  Anuwatnonthakate, Amornrat ^a   Limsomboon, Pranom ^b   Nateniyom, Sriprapa ^a   Wattanaamornkiat, Wanpen ^c   Komsakorn, Sittijate ^d   Moolphate, Saiyud ^e   Chiengsorn, Navarat ^f   Kaewsa ard, Samroui ^g   Sombat, Potjaman ^a   Siangphoe, Umaporn ^a   Mock, Philip A ^a   Varma, Jay K ^a,h  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b Phuket Provincial Health Office   (Thailand)

^c Office of Disease Prevention and Control 7   (Thailand)

^d Chiang Rai Provincial Public Health Office   (Thailand)

^e RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^f Bangkok Metropolitan Health Administration   (Thailand)

^g Bamrasnaradura Infectious Disease Institute   (Thailand)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DIRECTLY OBSERVED THERAPY; FAMILY COUNSELING; FEMALE; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; SELF CARE; SPUTUM SMEAR; THAILAND; TREATMENT OUTCOME; COST OF ILLNESS; INTERNATIONAL COOPERATION; MIDDLE AGED; MULTIDRUG RESISTANCE; PATIENT SELECTION; PRESCHOOL CHILD; PUBLIC HEALTH SERVICE; TUBERCULOSIS; UNITED STATES;

ADOLESCENT; ADULT; AGED; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; INFANT; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; PATIENT SELECTION; THAILAND; TREATMENT OUTCOME; TUBERCULOSIS; UNITED STATES;

EID: 52449116203     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0003089     Document Type: Article

References (24)

1. World Health Organization (2007) Global tuberculosis control: surveillance, planning, financing. WHO report 2007. Geneva, Switzerland: World Health Organization. (WHO/HTM/TB/2007.376).
2. Bayer R, Wilkinson D (1995) Directly observed therapy for tuberculosis control: history of an idea. Lancet 345: 1545-48.
3. Maartens G, Wilkinson RJ (2007) Tuberculosis. Lancet 370: 2030-43.
4. Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC (2005) Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. J Am Med Assoc 293: 2767-75.
5. Hopewell PC, Pai M, Maher D, Uplekar M, Raviglione MC (2006) International standards for tuberculosis care. Lancet Infect Dis 6: 710-25.
6. Volmink J, Garner P (2006) Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2: CD003343.
7. Rusen ID, Ait-Khaled N, Alarcon E (2007) Cochrane systematic review of directly observed therapy for treating tuberculosis: good analysis of the wrong outcome. Int J Tuberc Lung Dis 11: 120-121.
8. Frieden T, Sbarbaro JA (2002) The slippery slope to sloppy DOTS. Int J Tuberc Lung Dis 6: 271-272.
9. D'Agostino RB, Jr., D'Agostino RB, Sr (2007) Estimating treatment effects using observational data. J Am Med Assoc 297: 314-316.
10. World Health Organization South-East Asia Regional Office (2004) Third Review of the National Tuberculosis Programme in Thailand, 17-28 November 2003. New Delhi, India: World Health Organization; 2004. (SEA-TB-267)
11. Varma JK, Wiriyakitjar D, Nateniyom S, Anuwatnonthakate A, Monkongdee P, et al. (2007) Evaluating the potential impact of the new Global Plan to Stop TB: Thailand, 2004-2005. Bull World Health Organ 85: 586-592.
12. World Health Organisation (2003) Treatment of tuberculosis: Guidelines for national programmes. Geneva, Switzerland: World Health Organization.
13. Zignol M, Wright A, Jaramillo E, Nunn P, Raviglione MC (2007) Patients with previously treated tuberculosis: No longer neglected. Clin Infec Dis 44: 61-64.
14. Munro SA, Lewin SA, Smith H, Engel ME, Fretheim A, et al. (2007) Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Med 4: e238.
15. Rubin DB (1997) Estimating causal effects from large data sets using propensity scores. Ann Intern Med 127: 757-763.
16. Joffe MM, Rosenbaum PR (1999) Invited commentary: propensity scores. Am J Epidemiol 150: 327-333.
17. Pungrassami P, Johnsen SP, Chongsuvivatwong V, Olsen J, Sorensen HT (2002) Practice of directly observed treatment for tuberculosis in southern Thailand: comparison between different types of DOT observers. Int J Tuberc Lung Dis 6: 389-395.
18. Akksilp S, Karnkawinpong O, Wattanaamornkiat W, Viriyakitja D, Monkongdee P, et al. (2007) Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerg Infect Dis 13: 1001-7.
19. Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko, AG, et al. (2000) Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. J Am Med Assoc 283: 2537-45.
20. Pungrassami P, Johnsen SP, Chongsuvivatwong V, Olsen J (2002) Has directly observed treatment improved outcomes for patients with tuberculosis in southern Thailand? Trop Med Int Health 7: 271-79.
21. Akksilp S, Rasmithat S, Maher D, Sawert H (1999) Direct observation of tuberculosis treatment by supervised family members in Yasothorn Province, Thailand. Int J Tuberc Lung Dis 3: 1061-1065.
22. Kamolratanakul P, Sawert H, Lertmaharit S, Kasetjaroen Y, Akksilp S, et al. (1999) Randomized controlled trail of directly observed treatment for patients with pulmonary tuberculosis in Thailand. Trans Roy Soc Trop Med Hyg 93: 552-557.
23. Okanurak K, Kitayaporn D, Wanarangisikul W, Koompong C (2007) Effectiveness of DOT for tuberculosis treatment outcomes: a prospective cohort study in Bangkok, Thailand. Int J Tuberc Lung Dis 11: 762-68.
24. Newell JN, Baral SC, Pande SB, Bam DS, Malla P (2006) Family-member DOTS and community DOTS for tuberculosis control in Nepal: cluster-randomised controlled trial. Lancet 367: 903-09.